Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,060 | 180,211 | 325,389 | 461,225 | 82,447 |
| Marketable Securities | 334,561 | 451,505 | 447,229 | 583,675 | 237,203 |
| Receivables | 27,524 | 36,615 | 18,786 | 24,241 | 16,837 |
| Inventories | 58,755 | 56,676 | 50,381 | 24,599 | 14,230 |
| TOTAL | $495,681 | $742,047 | $852,074 | $1,101,134 | $355,587 |
| Non-Current Assets | |||||
| PPE Net | 30,505 | 36,432 | 41,580 | 32,504 | 24,899 |
| Intangibles | 707,333 | 919,245 | 820,219 | 820,953 | 0 |
| Other Non-Current Assets | 26,928 | 48,289 | 53,213 | 52,379 | 33,494 |
| TOTAL | $764,766 | $1,003,966 | $915,012 | $905,836 | $58,393 |
| Total Assets | $1,260,447 | $1,746,013 | $1,767,086 | $2,006,970 | $413,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,590 | 15,062 | 12,028 | 11,002 | 3,579 |
| Accrued Expenses | 22,595 | 45,708 | 32,596 | 36,261 | 17,350 |
| Other current liabilities | 3,224 | 8,326 | 179,327 | 5,759 | 4,519 |
| TOTAL | $66,299 | $95,029 | $263,335 | $71,709 | $38,502 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13,864 | 16,342 | 30,498 | 10,977 | 8,722 |
| Other Non-Current Liabilities | 681,654 | 944,150 | 939,053 | 1,119,225 | 38,419 |
| TOTAL | $687,554 | $949,680 | $940,847 | $1,144,274 | $39,987 |
| Total Liabilities | $753,853 | $1,044,709 | $1,204,182 | $1,215,983 | $78,489 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 297,852 | 267,952 | 247,079 | 221,183 | 193,103 |
| Common Shares | 294 | 268 | 227 | 221 | 192 |
| Retained earnings | -2,148,926 | -1,839,075 | -1,532,340 | -1,218,092 | -1,036,869 |
| Other shareholders' equity | 422 | 219 | -4,765 | -1,087 | 85 |
| TOTAL | $506,594 | $701,304 | $562,904 | $790,987 | $335,491 |
| Total Liabilities And Equity | $1,260,447 | $1,746,013 | $1,767,086 | $2,006,970 | $413,980 |